Suppr超能文献

相似文献

1
Oligomeric forms of single chain immunoglobulin (scIgG).
MAbs. 2010 Jan-Feb;2(1):73-6. doi: 10.4161/mabs.2.1.10784. Epub 2010 Jan 26.
3
Construction of affinity changeable antibody in response to Ca2+.
Biotechnol Lett. 2012 Jun;34(6):1019-23. doi: 10.1007/s10529-012-0881-z. Epub 2012 Feb 21.
6
Engineered antibody intervention strategies for Alzheimer's disease and related dementias by targeting amyloid and toxic oligomers.
Protein Eng Des Sel. 2009 Mar;22(3):199-208. doi: 10.1093/protein/gzn052. Epub 2008 Oct 16.
9
Multi-Angle Effector Function Analysis of Human Monoclonal IgG Glycovariants.
PLoS One. 2015 Dec 11;10(12):e0143520. doi: 10.1371/journal.pone.0143520. eCollection 2015.

引用本文的文献

1
Toward Antibody Production in Genome-Minimized Strains.
ACS Synth Biol. 2025 Mar 21;14(3):740-755. doi: 10.1021/acssynbio.4c00688. Epub 2025 Feb 27.
2
Engineering resilient CAR T cells for immunosuppressive environment.
Mol Ther. 2025 Jun 4;33(6):2391-2405. doi: 10.1016/j.ymthe.2025.01.035. Epub 2025 Jan 25.
3
Can antibodies be "vegan"? A guide through the maze of today's antibody generation methods.
MAbs. 2024 Jan-Dec;16(1):2343499. doi: 10.1080/19420862.2024.2343499. Epub 2024 Apr 18.
4
Comparative performance of scFv-based anti-BCMA CAR formats for improved T cell therapy in multiple myeloma.
Cancer Immunol Immunother. 2024 Apr 17;73(6):100. doi: 10.1007/s00262-024-03688-4.
5
Targeting CD22 for B-cell hematologic malignancies.
Exp Hematol Oncol. 2023 Oct 11;12(1):90. doi: 10.1186/s40164-023-00454-7.
6
"Hurdles race for CAR T-cell therapy in digestive tract cancer".
Immunol Rev. 2023 Nov;320(1):100-119. doi: 10.1111/imr.13273. Epub 2023 Sep 11.
7
CAR-T cell potency: from structural elements to vector backbone components.
Biomark Res. 2022 Sep 19;10(1):70. doi: 10.1186/s40364-022-00417-w.
8
Antigen-independent activation enhances the efficacy of 4-1BB-costimulated CD22 CAR T cells.
Nat Med. 2021 May;27(5):842-850. doi: 10.1038/s41591-021-01326-5. Epub 2021 Apr 22.
9
Conjugation of an scFab domain to the oligomeric HIV envelope protein for use in immune targeting.
PLoS One. 2019 Aug 20;14(8):e0220986. doi: 10.1371/journal.pone.0220986. eCollection 2019.
10
The making of bispecific antibodies.
MAbs. 2017 Feb/Mar;9(2):182-212. doi: 10.1080/19420862.2016.1268307.

本文引用的文献

1
Efficient recovery of high-affinity antibodies from a single-chain Fab yeast display library.
J Mol Biol. 2009 Jun 5;389(2):365-75. doi: 10.1016/j.jmb.2009.04.019. Epub 2009 Apr 16.
2
Production of single chain Fab (scFab) fragments in Bacillus megaterium.
Microb Cell Fact. 2007 Nov 27;6:38. doi: 10.1186/1475-2859-6-38.
3
Analysis of IgG heavy chain to light chain ratio with mutant Encephalomyocarditis virus internal ribosome entry site.
Protein Eng Des Sel. 2007 Oct;20(10):491-6. doi: 10.1093/protein/gzm038. Epub 2007 Oct 20.
4
Whole IgG surface display on mammalian cells: Application to isolation of neutralizing chicken monoclonal anti-IL-12 antibodies.
J Immunol Methods. 2007 Oct 31;327(1-2):40-52. doi: 10.1016/j.jim.2007.07.007. Epub 2007 Aug 2.
5
Isolation of engineered, full-length antibodies from libraries expressed in Escherichia coli.
Nat Biotechnol. 2007 May;25(5):563-5. doi: 10.1038/nbt1296. Epub 2007 Apr 15.
6
Single chain Fab (scFab) fragment.
BMC Biotechnol. 2007 Mar 8;7:14. doi: 10.1186/1472-6750-7-14.
7
A comparative study of different vector designs for the mammalian expression of recombinant IgG antibodies.
J Immunol Methods. 2007 Jan 10;318(1-2):113-24. doi: 10.1016/j.jim.2006.10.010. Epub 2006 Nov 13.
9
Antigen binding and stability properties of non-covalently linked anti-CD22 single-chain Fv dimers.
FEBS Lett. 2004 Dec 17;578(3):257-61. doi: 10.1016/j.febslet.2004.11.011.
10
Expression of full-length immunoglobulins in Escherichia coli: rapid and efficient production of aglycosylated antibodies.
J Immunol Methods. 2002 May 1;263(1-2):133-47. doi: 10.1016/s0022-1759(02)00036-4.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验